window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Delivery & Formulation

  • Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development,Research & Development

    Circio and Full Circles Therapeutics combine technologies for in vivo cell therapy

    Circio and Full Circles Therapeutics are combining circular RNA and [...]

    August 27, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development

    Lonza launches rapid custom media service for early bioprocess development

    Lonza has launched a custom media prototyping service designed to [...]

    August 24, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Delivery & Formulation,Manufacturing & Supply Chain,Medical devices

    Germfree and Nuvai add AI monitoring to IV compounding

    Germfree and Nuvai Medical Technologies are partnering to integrate AI-powered [...]

    August 19, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Dunbar Pharma brings plant-derived dronabinol API to UK through IPS Pharma

    Dunbar Pharma has made its plant-derived dronabinol active pharmaceutical ingredient [...]

    August 20, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease

    The FDA has accepted Belite Bio’s application for tinlarebant and [...]

    August 13, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Calla Lily selected for $50M Wellcome Leap antibiotic programme

    Calla Lily Clinical Care has been selected for Wellcome Leap’s [...]

    August 12, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development

    Piramal Pharma Solutions expands peptide API facility with spray drying suite

    Piramal Pharma Solutions has expanded its dedicated peptide development and [...]

    August 4, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Delivery & Formulation,Pharmaceuticals and therapeutics

    PolyPid’s D-PLEX100 receives FDA Priority Review for surgical site infection prevention

    PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]

    July 29, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    ProBioGen and VarmX partner on second Factor X candidate

    ProBioGen and VarmX have entered a collaboration to develop a [...]

    July 29, 2026
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development

    FDA allows Medicus Pharma to start SkinJect study in patients with Gorlin Syndrome

    Medicus Pharma has received FDA clearance to begin a Phase [...]

    July 28, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Piramal Pharma reports 22.6% emissions reduction and zero OAI observations in sustainability report
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
  • FDA approves ViiV’s Tivicay PD for young children with HIV
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Centrix and University of Sussex launch £375,000 data science project for drug development
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top